Profectus BioSciences, Inc.   Report issue

For profit Phase 1
Founded: Baltimore MD United States (2002)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2011
NCT01496989
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Profectus BioSciences, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhagic Fever, Ebola (Phase 1)

Henipavirus Infections (Phase 1)

HIV Infections (Phase 1)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 5
  • # of Trial APIs: 8